FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Minji Jo

Research Profile

Chemicals & Drugs

Physiology

Phenomena

Anatomy

Disorders

Breast Neoplasms

Living Beings

Mouse

Co-author Network

Publications

TOP 3
Jeanne M Bristow; Steven L Gonias; Minji Jo; Theresa A Reno; Richard L Klemke
Dynamic phosphorylation of tyrosine 665 in pseudopodium-enriched atypical kinase 1 (PEAK1) is essential for the regulation of cell migration and focal adhesion turnover.
Jingjing Hu; Minji Jo; Scott R VandenBerg; Webster K Cavenee; Frank B Furnari; Steven L Gonias
Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells.
Steven L Gonias; Alban Gaultier; Minji Jo
Regulation of the urokinase receptor (uPAR) by LDL receptor-related protein-1 (LRP1).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Minji Jo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jeanne M Bristow; Steven L Gonias; Minji Jo; Theresa A Reno; Richard L Klemke
Dynamic phosphorylation of tyrosine 665 in pseudopodium-enriched atypical kinase 1 (PEAK1) is essential for the regulation of cell migration and focal adhesion turnover.
The Journal of biological chemistry 2013;288(1):123-31.
2011: Jingjing Hu; Minji Jo; Scott R VandenBerg; Webster K Cavenee; Frank B Furnari; Steven L Gonias
Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(38):15984-9.
2011: Steven L Gonias; Alban Gaultier; Minji Jo
Regulation of the urokinase receptor (uPAR) by LDL receptor-related protein-1 (LRP1).
Current pharmaceutical design 2011;17(19):1962-9.
2010: Minji Jo; Boryana M Eastman; Drue L Webb; Konstantin Stoletov; Richard Klemke; Steven L Gonias
Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cells.
Cancer research 2010;70(21):8948-58.
2010: Elisabetta Mantuano; Minji Jo; Steven L Gonias; W Marie Campana
Low density lipoprotein receptor-related protein (LRP1) regulates Rac1 and RhoA reciprocally to control Schwann cell adhesion and migration.
The Journal of biological chemistry 2010;285(19):14259-66.
2009: Minji Jo; Robin D Lester; Valerie Montel; Boryana Eastman; Shinako Takimoto; Steven L Gonias
Reversibility of epithelial-mesenchymal transition (EMT) induced in breast cancer cells by activation of urokinase receptor-dependent cell signaling.
The Journal of biological chemistry 2009;284(34):22825-33.
2007: Robin D Lester; Minji Jo; Valerie Montel; Shinako Takimoto; Steven L Gonias
uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells.
The Journal of cell biology 2007;178(3):425-36.
2007: Minji Jo; Keena S Thomas; S Takimoto; Alban Gaultier; E H Hsieh; Robin D Lester; Steven L Gonias
Urokinase receptor primes cells to proliferate in response to epidermal growth factor.
Oncogene 2007;26(18):2585-94.
2005: Robin D Lester; Minji Jo; W Marie Campana; Steven L Gonias
Erythropoietin promotes MCF-7 breast cancer cell migration by an ERK/mitogen-activated protein kinase-dependent pathway and is primarily responsible for the increase in migration observed in hypoxia.
The Journal of biological chemistry 2005;280(47):39273-7.
2005: Wendy M Mars; Minji Jo; Steven L Gonias
Activation of hepatocyte growth factor by urokinase-type plasminogen activator is ionic strength-dependent.
The Biochemical journal 2005;390(Pt 1):311-5.
2005: Minji Jo; Keena S Thomas; Nadzeya Marozkina; Tanay J Amin; Corinne M Silva; Sarah J Parsons; Steven L Gonias
Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator.
The Journal of biological chemistry 2005;280(17):17449-57.
2003: Minji Jo; Keena S Thomas; Lihua Wu; Steven L Gonias
Soluble urokinase-type plasminogen activator receptor inhibits cancer cell growth and invasion by direct urokinase-independent effects on cell signaling.
The Journal of biological chemistry 2003;278(47):46692-8.
2003: Minji Jo; Keena S Thomas; Denise M O'Donnell; Steven L Gonias
Epidermal growth factor receptor-dependent and -independent cell-signaling pathways originating from the urokinase receptor.
The Journal of biological chemistry 2003;278(3):1642-6.
2002: Minji Jo; Keena S Thomas; Avril V Somlyo; Andrew P Somlyo; Steven L Gonias
Cooperativity between the Ras-ERK and Rho-Rho kinase pathways in urokinase-type plasminogen activator-stimulated cell migration.
The Journal of biological chemistry 2002;277(14):12479-85.
2001: Z Ma; Donna J Webb; Minji Jo; Steven L Gonias
Endogenously produced urokinase-type plasminogen activator is a major determinant of the basal level of activated ERK/MAP kinase and prevents apoptosis in MDA-MB-231 breast cancer cells.
Journal of cell science 2001;114(Pt 18):3387-96.
2000: Minji Jo; Tae-Hyoung Kim; Dai-Wu Seol; James Esplen; K Dorko; Timothy R Billiar; Stephen C Strom
Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand.
Nature medicine 2000;6(5):564-7.
2000: Minji Jo; Donna B Stolz; James Esplen; K Dorko; George K Michalopoulos; Stephen C Strom
Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells.
The Journal of biological chemistry 2000;275(12):8806-11.
1997: S C Presnell; Donna B Stolz; Wendy M Mars; Minji Jo; George K Michalopoulos; Stephen C Strom
Modifications of the hepatocyte growth factor/c-met pathway by constitutive expression of transforming growth factor-alpha in rat liver epithelial cells.
Molecular carcinogenesis 1997;18(4):244-55.